Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrew S. Horne"'
Autor:
Kade D. Roberts, Yan Zhu, Mohammad A. K. Azad, Mei-Ling Han, Jiping Wang, Lynn Wang, Heidi H. Yu, Andrew S. Horne, Jo-Anne Pinson, David Rudd, Nicolas H. Voelcker, Nitin A. Patil, Jinxin Zhao, Xukai Jiang, Jing Lu, Ke Chen, Olga Lomovskaya, Scott J. Hecker, Philip E. Thompson, Roger L. Nation, Michael N. Dudley, David C. Griffith, Tony Velkov, Jian Li
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
Polymyxins are often the last therapeutic option for multidrug-resistant (MDR) bacteria, but have suboptimal safety and efficacy. Here the authors report the discovery and development of a synthetic lipopeptide with an improved safety and efficacy ag
Externí odkaz:
https://doaj.org/article/0e3e6c3ab9774848b67a0f077533e996
Autor:
Kelly L. Rogers, Mohammad Abul Kalam Azad, Kade D. Roberts, Roger L. Nation, Tony Velkov, James D. Swarbrick, Philip E. Thompson, Andrew S. Horne, Jian Li, Zakuan Zainy Deris, Jesmin Akter
Publikováno v:
Bioconjugate Chemistry
The dry antibiotic development pipeline coupled with the emergence of multidrug resistant Gram-negative ‘superbugs’ has driven the revival of the polymyxin lipopeptide antibiotics. Polymyxin resistance implies a total lack of antibiotics for the
Autor:
Philip E. Thompson, Mohammad Abul Kalam Azad, Kade D. Roberts, Andrew S. Horne, Jiping Wang, Jian Li, Tony Velkov, Roger L. Nation
Publikováno v:
ACS infectious diseases. 1(11)
Polymyxin B and colistin are currently used as a ‘last-line’ treatment for multidrug-resistant Gram-negative bacteria. However very little is known about the pharmacological differences between polymyxin B1, polymyxin B2, colistin A, colistin B,
Autor:
Andrew S. Horne
Publikováno v:
Bulletin of the Royal College of Psychiatrists. 8:27-28
Publikováno v:
Psychiatric Bulletin. 11:11-12